- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Group 3 PH
Total 271715 results
-
University of Medicine and Pharmacy at Ho Chi Minh...CompletedGastroesophageal RefluxVietnam
-
University of Erlangen-Nürnberg Medical SchoolUnknownEvaluate Bone Changes in Patients With PsAGermany
-
IRCCS Policlinico S. MatteoCompletedEpistaxis | Hereditary Hemorrhagic TelangiectasiaItaly
-
Liberty Mutual Research Institute for SafetyCompletedChronic Physical Health ConditionsUnited States
-
The George Institute for Global Health, ChinaCompletedAcute Coronary SyndromesChina
-
National Cancer Institute (NCI)TerminatedStage III Grade 1 Follicular Lymphoma | Stage III Grade 2 Follicular Lymphoma | Stage III Grade 3 Follicular Lymphoma | Stage IV Grade 1 Follicular Lymphoma | Stage IV Grade 2 Follicular Lymphoma | Stage IV Grade 3 Follicular LymphomaUnited States
-
Mario Negri Institute for Pharmacological ResearchAgenzia Italiana del Farmaco; Associazione Culturale PediatriCompletedRespiratory Tract Infections | Respiratory Sounds | Bronchial SpasmItaly
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Yooyoung Pharmaceutical Co., Ltd.CompletedWrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial FoldsKorea, Republic of
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Azienda Ospedaliero, Universitaria PisanaCompletedAnesthesia | Post Operative PainItaly
-
ACO Hud Nordic ABSmerud Medical Research International ASCompleted
-
Cairo UniversityNot yet recruiting
-
XenoTherapeutics, Inc.Joseph M. Still Research Foundation, Inc.RecruitingWound Heal | Thermal Burn | Burn Degree Second | Burns Degree Third | Burn (Disorder)United States
-
PepsiCo Global R&DUnknownChange in Cognitive Function and Fatigue During Extended Performance of the Cognitive Demand Battery (CDB) at 1, 3 and 6 Hours Post Consumption | Change in Long Term Declarative Memory at 1, 3 and 6 Hours Post-intervention.United Kingdom
-
AbbVieRecruiting
-
Eisai Co., Ltd.CompletedPartial-onset SeizuresKorea, Republic of, Japan, Australia, China, Malaysia, Taiwan, Thailand
-
National Taiwan University HospitalCompletedPatients Admitted to the ICU More Than 3 Days Post-onsetTaiwan
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Unknown
-
Universitat Internacional de CatalunyaKing's College London; Universidad de Murcia; Universidad Complutense de Madrid; Universidad de Granada and other collaboratorsRecruitingPeriodontitis | Periodontal Disease, AVDC Stage 3 | Periodontal Disease, AVDC Stage 4Spain
-
Hallym University Kangnam Sacred Heart HospitalUnknownPatients Receiving Protective Lung Ventilation | Patients in Grey Zone (3 < Pulse Pressure Variation (PPV) < 17Korea, Republic of
-
University of JordanCompletedDiagnosis of GHD With IGF-I/IGFBP-3 Ratio
-
Shiraz University of Medical SciencesCompletedRenal Pelvis Stone >3cmIran, Islamic Republic of
-
Mitsubishi Tanabe Pharma CorporationThe Research Foundation for Microbial Diseases of Osaka UniversityCompleted
-
AVEO Pharmaceuticals, Inc.CompletedMultiple Myeloma | Lymphomas | Malignant Solid TumorUnited States
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemia | Familial HypercholesterolemiaCanada
-
Centre Hospitalier Universitaire DijonTerminatedEpidermoid Carcinoma or | Adenocarcinoma of the Thoracic Oesophagus or | Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II) | Stage cT2 N1-3 M0 or cT3-T4a N0 or N1-3 M0France
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Germany, United Kingdom, Italy, Austria, Canada
-
Vanderbilt UniversitySigma Theta Tau International, Iota chapter; Sigma Theta Tau International,... and other collaboratorsCompletedBleeding | Childbirth | Third Stage of Labor | Guided ImageryUnited States
-
Instituto Venezolano de Investigaciones CientificasHospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, Yaracuy; Unidad... and other collaboratorsEnrolling by invitation
-
AblynxCompletedRespiratory Syncytial Virus InfectionAustralia, Belgium, Bulgaria, Estonia, Hungary, Israel, Latvia, Malaysia, Philippines, Poland, Slovakia, Spain, Thailand, United Kingdom
-
University Hospital Schleswig-HolsteinUniversity of LuebeckRecruitingSplit-skin Grafted Third-degree Burn WoundGermany
-
Novartis PharmaceuticalsRoche Pharma AGCompletedAdenocarcinoma | Carcinoma | Renal Cell | Nephroid Carcinoma | HypernephroidBelgium, Italy, Spain, United Kingdom, Germany, Taiwan, Turkey, Egypt, Hong Kong, Russian Federation, Switzerland, Thailand, France, Netherlands, Korea, Republic of, Brazil, United States, Czech Republic, South Africa, Hungary, ...
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Grade 3 Follicular Lymphoma | Plasmablastic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Primary Effusion Lymphoma | AIDS-Related Primary Effusion Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor... and other conditionsUnited States
-
Shanghai Henlius BiotechCompleted
-
Ruhr University of BochumNot yet recruitingOne Week Follow-up Assessment | Six Weeks Follow-up Assessment | Three Months Follow-up AssessmentGermany
-
Shanghai Henlius BiotechCompleted
-
PfizerTerminated
-
Novartis VaccinesCompleted
-
Vanderbilt UniversityUniversity of California, IrvineCompletedCondition 1 - Educational Condition (Educational Book Group) | Condition 2 - Non-educational Condition (Non-educational Book Group) | Condition 3 - Control Condition (No-book Group)United States
-
TheracosCompletedType 2 Diabetes MellitusGermany, United States, Spain, Poland
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Mersin UniversityCompletedHealthy | Infant Conditions | Third Stage of Labor | Umbilical Cord Clamping TimeTurkey
-
Shengjing HospitalEnrolling by invitation
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
AquaPass Medical Ltd.Not yet recruitingChronic Heart Failure | CKD Stage 3Israel, United States
-
McMaster UniversityNational Hemophilia Foundation; Patient Outcomes Research Group (PORG)RecruitingHemophilia | Chronic DiseaseCanada
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Wellcome Trust; Heart and Stroke... and other collaboratorsCompletedCardiovascular Disease | Fractures | CancersCanada, India, Bangladesh, Colombia, Indonesia, Malaysia, Philippines, Tanzania, Tunisia